Cite
HARVARD Citation
Rosenthal, E. et al. (2020). Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine. 38 (51), pp. 8206-8215. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rosenthal, E. et al. (2020). Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine. 38 (51), pp. 8206-8215. [Online].